This is a StreetInsider.com Premium Only Page

(ENOB) – Globe Newswire

Feb 14, 2024 10:01 AM Statement of Renovaro Inc

Feb 13, 2024 09:46 AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Feb 13, 2024 09:31 AM AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Oct 2, 2023 12:05 PM Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

Aug 30, 2023 09:15 AM Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

Jun 23, 2023 05:00 PM Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

Jun 8, 2023 08:45 AM Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

Apr 3, 2023 09:00 AM Enochian BioSciences’ CEO Letter to Shareholders

Apr 3, 2023 09:00 AM Enochian BioSciences’ CEO Letter to Shareholders

Mar 29, 2023 09:00 AM Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

Mar 29, 2023 09:00 AM Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

Mar 13, 2023 08:30 AM Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

Mar 13, 2023 08:30 AM Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

Feb 23, 2023 04:04 PM Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

Feb 23, 2023 04:04 PM Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

Nov 30, 2022 05:20 PM Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

Nov 30, 2022 05:20 PM Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

Oct 24, 2022 08:00 AM Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

Oct 24, 2022 08:00 AM Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

Oct 21, 2022 05:00 PM Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

Oct 17, 2022 08:30 AM Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

Sep 26, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, Coinbase, and Carvana and Encourages Investors to Contact the Firm

Sep 22, 2022 08:17 PM UPDATE -- Edelson Lechtzin LLP Reminds Enochian Biosciences, Inc. Investors of the Impending Lead Plaintiff Deadline

Sep 22, 2022 06:37 PM Edelson Lechtzin LLP Reminds Enochian Biosciences, Inc. Investors of the Impending Lead Plaintiff Deadline

Sep 21, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, Coinbase, and Fulgent and Encourages Investors to Contact the Firm

Sep 16, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 17EdTech, Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Sep 11, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, Coinbase, and Carvana and Encourages Investors to Contact the Firm

Sep 9, 2022 10:29 AM Edelson Lechtzin LLP Notifies Enochian Biosciences, Inc. Investors of a Class Action Lawsuit

Sep 6, 2022 09:26 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Molecular Partners, TG Therapeutics, 17EdTech, and Enochian and Encourages Investors to Contact the Fir

Aug 31, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Molecular Partners, TG Therapeutics, 17EdTech, and Enochian and Encourages Investors to Contact the Fir

Aug 26, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, Coinbase, and Carvana and Encourages Investors to Contact the Firm

Aug 21, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 17EdTech, Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Aug 15, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TG Therapeutics, 17EdTech, Enochian, and Weber and Encourages Investors to Contact the Firm

Aug 10, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Aug 5, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, Coinbase, and Carvana and Encourages Investors to Contact the Firm

Jul 31, 2022 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian and Weber and Encourages Investors to Contact the Firm

Jul 25, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Cassava, and Hannon Armstrong and Encourages Investors to Contact the Firm

Jul 25, 2022 10:15 AM Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

Jul 25, 2022 10:15 AM Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

Jul 20, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and the WWE and Encourages Investors to Contact the Firm

Jul 15, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm

Jul 10, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating RBB, Agrify, Carvana, and Enochian and Encourages Investors to Contact the Firm

Jul 4, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Enochian, Corcept, Rollins, and Target and Encourages Investors to Contact the Firm

Jul 1, 2022 05:00 PM Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data

Jul 1, 2022 05:00 PM Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data

Jun 29, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Agrify, Carvana, Enochian, and Corcept and Encourages Investors to Contact the Firm

Jun 24, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Unity, Carvana, Enochian, and Corcept and Encourages Investors to Contact the Firm

Jun 19, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Corcept, and Clariant and Encourages Investors to Contact the Firm

Jun 13, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm

Jun 8, 2022 09:00 PM Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Novartis, and Corcept and Encourages Investors to Contact the Firm